Innovation and the pharmaceutical industry  critical reflections on the virtues of profit /  [electronic resource] : 
edited by H. Tristram Engelhardt Jr. and Jeremy R. Garrett. 
 - Salem, MA :  M & M Scrivener Press,  c2008. 
 - viii, 245 p. 
 - Trends and conflicts .
 - Conflicts and trends. .
<br/><br/>Includes bibliographical references and index. 
<br/><br/>Pharmaceutical innovation and the market: the pursuit of profit and the amelioration of the human condition / H. Tristram Engelhardt Jr. & Jeremy R. Garrett -- The unavoidable goodness of profit: the cunning of reason and the realization of human well-being / H. Tristram Engelhardt Jr -- Corporate social responsibility and business ethics in the pharmaceutical industry / Nicholas Capaldi -- Pharmaceutical companies: psychopaths or scapegoats / Pepe Lee Chang -- Autonomy, constraining options, and pharmaceutical costs / James Stacy Taylor -- Pharmaceutical advertising and patient autonomy / Andrew I. Cohen -- Does America have a second drug problem? / Richard A. Epstein -- Global drug innovation in a world of financial finitude: retailing virtue to promote -- Capital formation and profit / Michael A. Rie -- Time, money, and the market for drugs / John C. Goodman -- Perils of parallel trade: reimporting prescription drugs from Canada to the U.S. / John R. Graham -- Risk, responsibility, and litigation / Sandra H. Johnson & Ana Smith Iltis. 
<br/><br/><br/>Electronic reproduction. Ann Arbor, MI : ProQuest, 2015. Available via World Wide Web. Access may be limited to ProQuest affiliated libraries. 
<br/><br/><label>ISBN: </label>
<br/><br/><label>LCCN: </label>
<br/><br/><label>Subjects--Topical Terms: </label><br/>Pharmaceutical industry.<br/>Drug development.<br/>Medical innovations.<br/>Medical policy--United States.<br/>Drugs--economics--United States.
<br/><br/><label>Index Terms--Genre/Form: </label><br/>Electronic books.
<br/><br/><label>LC Class. No.: </label>HD9665.5  / .I55 2008 
<br/><br/><label>Dewey Class. No.: </label>338.4/791510973